Tepotinib in non-small cell lung cancer with MET exon 14-skipping mutations or MET amplification: A phase 2 trial in progress Meeting Abstract


Authors: Paik, P.; Sakai, H.; Bruns, R.; Scheele, J.; Straub, J.; Felip, E.
Abstract Title: Tepotinib in non-small cell lung cancer with MET exon 14-skipping mutations or MET amplification: A phase 2 trial in progress
Meeting Title: IASLC Asia Conference on Lung Cancer 2018
Keywords: non-small cell lung cancer; met amplification; liquid biopsy; tepotinib
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 12 Suppl.
Meeting Dates: 2018 Nov 7-10
Meeting Location: Guangzhou, China
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-12-01
Start Page: S1046
Language: English
ACCESSION: WOS:000452742800007
PROVIDER: wos
DOI: 10.1016/j.jtho.2018.10.016
Notes: Meeting Abstract: OA06 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik